Neuroscience

Articles and news from the latest research reports.

Posts tagged science

25 notes


Fruit flies’ eyes shrink a little to see
I spy, with my mechanical eye. It seems a simple mechanical change plays a role in sensory perception in fruit flies, and possibly in many other animals, including humans.
The eyes of the common fruit fly (Drosophila melanogaster) contain clusters of light-sensitive cells organised into rods. When light strikes one of these cells, it triggers a series of chemical reactions. These cause a protein called a transient receptor potential (TRP) ion channel to open. When it’s open, the TRP allows charged particles to flow into the cell, causing the cell to send a signal to the fly’s brain.
TRP channels play a part in sensory perception in many animals, from nematodes to humans. But nobody knew how the chemical signals make the TRP channel open.

Fruit flies’ eyes shrink a little to see

I spy, with my mechanical eye. It seems a simple mechanical change plays a role in sensory perception in fruit flies, and possibly in many other animals, including humans.

The eyes of the common fruit fly (Drosophila melanogaster) contain clusters of light-sensitive cells organised into rods. When light strikes one of these cells, it triggers a series of chemical reactions. These cause a protein called a transient receptor potential (TRP) ion channel to open. When it’s open, the TRP allows charged particles to flow into the cell, causing the cell to send a signal to the fly’s brain.

TRP channels play a part in sensory perception in many animals, from nematodes to humans. But nobody knew how the chemical signals make the TRP channel open.

Filed under vision drosophila fruit flies cells TRP ion channel neuroscience science

44 notes

A Gene Implicated In Schizophrenia Risk Is Also Associated With Risk for Cannabis Dependence

A paper by Shizhong Han and colleagues in the current issue of Biological Psychiatry implicates a new gene in the risk for cannabis dependence. This gene, NRG1, codes for the ErbB4 receptor, a protein implicated in synaptic development and function.

The researchers set out to investigate susceptibility genes for cannabis dependence, as research has already shown that it has a strong genetic component.

To do this, they employed a multi-stage design using genetic data from African American and European American families. In the first stage, a linkage analysis, the strongest signal was identified in African Americans on chromosome 8p21. Then using a genome-wide association study dataset, they identified one genetic variant at NRG1 that showed consistent evidence for association in both African Americans and European Americans. Finally, they replicated the association of that same variant in an independent sample of African-Americans.

All together, the findings suggest that NRG1 may be a susceptibility gene for cannabis dependence.

An interesting feature of this paper is that these findings may also suggest a link between the genetics of schizophrenia and the genetics of cannabis dependence. NRG1 emerged into public awareness after a series of genetic studies implicated it in the heritable risk for schizophrenia. Subsequent studies in post-mortem brain tissue also suggested that the regulation of NRG1 was altered in the brains of individuals diagnosed with schizophrenia.

Thus, the current findings may help to explain the already established link between cannabis use and the risk for developing schizophrenia. A number of epidemiologic studies have attributed the association of cannabis use and schizophrenia to the effects of cannabis on the brain rather than a common genetic link between these two conditions.

"The current data provide a potentially important insight into the heritable risk for schizophrenia and raise the possibility that there are some common genetic contributions to these two disorders," commented Dr. John Krystal, Editor of Biological Psychiatry.

However, further research will be necessary to further confirm the role that NRG1 plays in cannabis dependence and the potential link between cannabis use and psychosis.

(Source: alphagalileo.org)

Filed under addiction cannabis cannabis dependence genes NRG1 schizophrenia genetics neuroscience science

174 notes

Ray Kurzweil, the bold futurist and author of The New York Times bestseller "The Singularity Is Near", is arguably today’s most influential technological visionary. A pioneering inventor and theorist, he has explored for decades how artificial intelligence can enrich and expand human capabilities.
Now, in his much-anticipated How to Create a Mind, he takes this exploration to the next step:  reverse-engineering the brain to understand precisely how it works, then applying that knowledge to create vastly intelligent machines.
Drawing on the most recent neuroscience research, his own research and inventions in artificial intelligence, and compelling thought experiments, he describes his new theory of how the neocortex (the thinking part of the brain) works: as a self-organizing hierarchical system of pattern recognizers. Kurzweil shows how these insights will enable us to greatly extend the powers of our own mind and provides a roadmap for the creation of superintelligence—humankind’s most exciting next venture. We are now at the dawn of an era of radical possibilities in which merging with our technology will enable us to effectively address the world’s grand challenges.
How to Create a Mind is certain to be one of the most widely discussed and debated science books in many years—a touchstone for any consideration of the path of human progress.

Ray Kurzweil, the bold futurist and author of The New York Times bestseller "The Singularity Is Near", is arguably today’s most influential technological visionary. A pioneering inventor and theorist, he has explored for decades how artificial intelligence can enrich and expand human capabilities.

Now, in his much-anticipated How to Create a Mind, he takes this exploration to the next step:  reverse-engineering the brain to understand precisely how it works, then applying that knowledge to create vastly intelligent machines.

Drawing on the most recent neuroscience research, his own research and inventions in artificial intelligence, and compelling thought experiments, he describes his new theory of how the neocortex (the thinking part of the brain) works: as a self-organizing hierarchical system of pattern recognizers. Kurzweil shows how these insights will enable us to greatly extend the powers of our own mind and provides a roadmap for the creation of superintelligence—humankind’s most exciting next venture. We are now at the dawn of an era of radical possibilities in which merging with our technology will enable us to effectively address the world’s grand challenges.

How to Create a Mind is certain to be one of the most widely discussed and debated science books in many years—a touchstone for any consideration of the path of human progress.

Filed under brain thinking Ray Kurzweil singularity neuroscience technology science

74 notes

Futurist Ray Kurzweil believes that the cloud will help expand the capacity of the human brain beyond its current limitations.
Futurist and author Ray Kurzweil predicts the cloud will eventually do more than store our emails or feed us streaming movies on demand: it’s going to help expand our brain capacity beyond its current limits.
In a question-and-answer session following a speech to the DEMO technology conference in Santa Clara, California last week, Kurzweil described the human brain as impressive but limited in its capacity to hold information. “By the time we’re even 20, we’ve filled it up,” he said, adding that the only way to add information after that point is to “repurpose our neocortex to learn something new.” (Computerworld has posted up the full video of the talk.)
The solution to overcoming the brain’s limitations, he added, involves “basically expanding our brains into the cloud.”
Kurzweil is one of the more prominent advocates of the technological Singularity, or the idea that computers will become super-intelligent and self-replicating, essentially reducing human progress to a sideshow. He is an optimist in this scenario, arguing in talks and books that the Singularity will effectively make humanity immortal by allowing us to transfer our consciousness into non-organic systems.

Futurist Ray Kurzweil believes that the cloud will help expand the capacity of the human brain beyond its current limitations.

Futurist and author Ray Kurzweil predicts the cloud will eventually do more than store our emails or feed us streaming movies on demand: it’s going to help expand our brain capacity beyond its current limits.

In a question-and-answer session following a speech to the DEMO technology conference in Santa Clara, California last week, Kurzweil described the human brain as impressive but limited in its capacity to hold information. “By the time we’re even 20, we’ve filled it up,” he said, adding that the only way to add information after that point is to “repurpose our neocortex to learn something new.” (Computerworld has posted up the full video of the talk.)

The solution to overcoming the brain’s limitations, he added, involves “basically expanding our brains into the cloud.”

Kurzweil is one of the more prominent advocates of the technological Singularity, or the idea that computers will become super-intelligent and self-replicating, essentially reducing human progress to a sideshow. He is an optimist in this scenario, arguing in talks and books that the Singularity will effectively make humanity immortal by allowing us to transfer our consciousness into non-organic systems.

Filed under brain brain limitations technology singularity Ray Kurzweil computer science neuroscience science

56 notes

Nerve signal discovery backs Nobel winner’s theory

Scientists have proved a 60-year-old theory about how nerve signals are sent around the body at varying speeds as electrical impulses.

Researchers tested how these signals are transmitted through nerve fibres, which enables us to move and recognise sensations such as touch and smell.

The findings from the University of Edinburgh have validated an idea first proposed by Nobel laureate Sir Andrew Huxley.

It has been known for many years that an insulating layer – known as myelin – which surrounds nerve fibres is crucial in determining how quickly these signals are sent.

This insulating myelin is interrupted at regular intervals along the nerve by gaps called nodes.

Scientists, whose work was funded by the Wellcome Trust, have now proved that the longer the distance between nodes, the quicker the nerve fibres send signals down the nerves.

The theory that the distance between these gaps might affect the speed of electrical signals was first proposed by Sir Andrew Huxley, who won the Nobel Prize in 1963 for his work on electrical signalling in the nervous system, and who died earlier this year.

The study, published in the journal Current Biology, will help provide insight into what happens in people with nerve damage. It will also shed light on how nerves develop before and after birth.

Professor Peter Brophy, Director of the University of Edinburgh’s Centre for Neuroregeneration, said: “The study gives us greater insight into how the central and peripheral nervous systems work and what happens after nerves become injured. We know that peripheral nerves have the capacity to repair, but shorter lengths of insulation around the nerve fibres after repair affect the speed with which impulses are sent around the body.”

The researchers found that when the myelin reached a certain length, the speed with which nerves impulses were conducted reached a peak.

The study, carried out in mice, also confirmed that a protein – periaxin – plays a key role in regulating the length of myelin layers around nerve fibres.

(Source: eurekalert.org)

Filed under nerve signals electrical signals periheral nerves nerve damage neuroscience biology science

42 notes

Mechanisms Underlying Childhood Neuromuscular Disease Found
A study by scientists from the Motor Neuron Center at Columbia University Medical Center (CUMC) suggests that spinal muscular atrophy (SMA), a genetic neuromuscular disease in infants and children, results primarily from motor circuit dysfunction, not motor neuron or muscle cell dysfunction, as is commonly thought. In a second study, the researchers identified the molecular pathway in SMA that leads to problems with motor function. Findings from the studies, conducted in fruit fly, zebrafish and mouse models of SMA, could lead to therapies for this debilitating and often fatal neuromuscular disease. Both studies were published today in the online edition of the journal Cell (1, 2).
“Scientists call SMA a motor neuron disease, and there is post-mortem evidence that it does cause motor neurons to die,” said Brian McCabe, PhD, assistant professor of pathology and cell biology and of neuroscience in the Motor Neuron Center, who led the first study. “However, it was not clear whether the death of motor neurons is a cause of the disease or an effect. Our findings in the fruit fly SMA model show that the disease originates in other motor circuit neurons, which then causes motor neurons to malfunction.”
In motor circuits, which coordinate muscle movement, specialized sensory neurons called proprioceptive neurons pick up and relay information to the spinal cord and brain about the body’s position in space. The central nervous system then processes and relays the signals, including via interneurons, to motor neurons, which in turn stimulate muscle movement.
“To our knowledge, this is the first clear demonstration in a model organism that defects in the function of a neuronal circuit are the cause of a neurological disease,” added Dr. McCabe.

Mechanisms Underlying Childhood Neuromuscular Disease Found

A study by scientists from the Motor Neuron Center at Columbia University Medical Center (CUMC) suggests that spinal muscular atrophy (SMA), a genetic neuromuscular disease in infants and children, results primarily from motor circuit dysfunction, not motor neuron or muscle cell dysfunction, as is commonly thought. In a second study, the researchers identified the molecular pathway in SMA that leads to problems with motor function. Findings from the studies, conducted in fruit fly, zebrafish and mouse models of SMA, could lead to therapies for this debilitating and often fatal neuromuscular disease. Both studies were published today in the online edition of the journal Cell (1, 2).

“Scientists call SMA a motor neuron disease, and there is post-mortem evidence that it does cause motor neurons to die,” said Brian McCabe, PhD, assistant professor of pathology and cell biology and of neuroscience in the Motor Neuron Center, who led the first study. “However, it was not clear whether the death of motor neurons is a cause of the disease or an effect. Our findings in the fruit fly SMA model show that the disease originates in other motor circuit neurons, which then causes motor neurons to malfunction.”

In motor circuits, which coordinate muscle movement, specialized sensory neurons called proprioceptive neurons pick up and relay information to the spinal cord and brain about the body’s position in space. The central nervous system then processes and relays the signals, including via interneurons, to motor neurons, which in turn stimulate muscle movement.

“To our knowledge, this is the first clear demonstration in a model organism that defects in the function of a neuronal circuit are the cause of a neurological disease,” added Dr. McCabe.

Filed under spinal muscular atrophy motor neurons interneurons drosophila neuroscience science

39 notes

Prospective Alzheimer’s drug builds new brain cell connections

Washington State University researchers have developed a new drug candidate that dramatically improves the cognitive function of rats with Alzheimer’s-like mental impairment.

Their compound, which is intended to repair brain damage that has already occurred, is a significant departure from current Alzheimer’s treatments, which either slow the process of cell death or inhibit cholinesterase, an enzyme believed to break down a key neurotransmitter involved in learning and memory development.

Such drugs, says Joe Harding, a professor in WSU’s College of Veterinary Medicine, are not designed to restore lost brain function, which can be done by rebuilding connections between nerve cells.

"This is about recovering function,” he says. "That’s what makes these things totally unique. They’re not designed necessarily to stop anything. They’re designed to fix what’s broken. As far as we can see, they work.”

Harding, College of Arts and Sciences Professor Jay Wright and other WSU colleagues report their findings in the online “Fast Forward” section of the Journal of Pharmacology and Experimental Therapeutics.

(Source: news.wsu.edu)

Read more …

Filed under brain alzheimer alzheimer's disease drugs treatment neuroscience brain cells science

143 notes

The Marshmallow Study Revisited
For the past four decades, the “marshmallow test” has served as a classic experimental measure of children’s self-control: will a preschooler eat one of the fluffy white confections now or hold out for two later?
Now a new study demonstrates that being able to delay gratification is influenced as much by the environment as by innate ability. Children who experienced reliable interactions immediately before the marshmallow task waited on average four times longer—12 versus three minutes—than youngsters in similar but unreliable situations [Video]
"Our results definitely temper the popular perception that marshmallow-like tasks are very powerful diagnostics for self-control capacity," says Celeste Kidd, a doctoral candidate in brain and cognitive sciences at the University of Rochester and lead author on the study to be published online October 11 in the journal Cognition.

The Marshmallow Study Revisited

For the past four decades, the “marshmallow test” has served as a classic experimental measure of children’s self-control: will a preschooler eat one of the fluffy white confections now or hold out for two later?

Now a new study demonstrates that being able to delay gratification is influenced as much by the environment as by innate ability. Children who experienced reliable interactions immediately before the marshmallow task waited on average four times longer—12 versus three minutes—than youngsters in similar but unreliable situations [Video]

"Our results definitely temper the popular perception that marshmallow-like tasks are very powerful diagnostics for self-control capacity," says Celeste Kidd, a doctoral candidate in brain and cognitive sciences at the University of Rochester and lead author on the study to be published online October 11 in the journal Cognition.

Filed under brain self-control children marshmallow study marshmallow test perception psychology neuroscience science

21 notes

New treatments for epilepsy, behavioral disorders could result from Wayne State University studies

Three studies conducted as part of Wayne State University’s Systems Biology of Epilepsy Project (SBEP) could result in new types of treatment for the disease and, as a bonus, for behavioral disorders as well.

The SBEP started out with funds from the President’s Research Enhancement Fund and spanned neurology, neuroscience, genetics and computational biology. It since has been supported by multiple National Institutes of Health-funded grants aimed at identifying the underlying causes of epilepsy, and it is uniquely integrated within the Comprehensive Epilepsy Program at the Wayne State School of Medicine and the Detroit Medical Center.

Under the guidance of Jeffrey Loeb, M.D., Ph.D., associate director of the Center for Molecular Medicine and Genetics (CMMG) and professor of neurology, the project brings together researchers from different fields to create an interdisciplinary research program that targets the complex disease. The multifaceted program at Wayne State is like no other in the world, officials say, with two primary goals: improving clinical care and creating novel strategies for diagnosis and treatment of patients with epilepsy.

(Source: research.wayne.edu)

Read more …

Filed under brain brain cells epilepsy treatment neuron neuroscience research science

25 notes


Target for obesity drugs comes into focus
Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain.
Leptin is a hormone secreted by fat tissue that has been of interest for researchers in obesity and Type 2 diabetes since it was discovered in 1995. Like insulin, leptin is part of a regulatory network that controls intake and expenditure of energy in the body, and a lack of leptin or resistance to it has been linked to obesity in people.
Although there can be several complex reasons behind leptin resistance, in some cases the underlying cause is malfunction of the leptin receptor in the brain. An understanding of how leptin and its receptor interact could lead to new treatments for obesity and metabolic disorders, but the structure of this signaling complex has evaded researchers for years.
Georgios Skiniotis, a faculty member at the Life Sciences Institute and assistant professor in biological chemistry at the U-M Medical School, employed electron microscopy to obtain the first picture of the interaction between leptin and its receptor.
Skiniotis also traced similarities between the leptin receptor and other receptors of the same family, which may provide insight into new targets for treatment of other hormone-related diseases.

Target for obesity drugs comes into focus

Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain.

Leptin is a hormone secreted by fat tissue that has been of interest for researchers in obesity and Type 2 diabetes since it was discovered in 1995. Like insulin, leptin is part of a regulatory network that controls intake and expenditure of energy in the body, and a lack of leptin or resistance to it has been linked to obesity in people.

Although there can be several complex reasons behind leptin resistance, in some cases the underlying cause is malfunction of the leptin receptor in the brain. An understanding of how leptin and its receptor interact could lead to new treatments for obesity and metabolic disorders, but the structure of this signaling complex has evaded researchers for years.

Georgios Skiniotis, a faculty member at the Life Sciences Institute and assistant professor in biological chemistry at the U-M Medical School, employed electron microscopy to obtain the first picture of the interaction between leptin and its receptor.

Skiniotis also traced similarities between the leptin receptor and other receptors of the same family, which may provide insight into new targets for treatment of other hormone-related diseases.

Filed under biochemistry brain hormone leptin neuroscience obesity obesity drugs science

free counters